|
 |
LoracarbefThis page contains recent news articles, when available, and an overview of Loracarbef but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Loracarbef (loe-ra-KAR-bef) is used to treat bacterial infections in many different parts of the body. It works by killing bacteria or preventing their ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com LORACARBEF (Oral route) - lor-a-KAR-bef.(Drug overview) - May 1, 2007 Loracarbef is used to treat bacterial infections in many different parts of the body. It works by killing bacteria or preventing their growth. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Serum sickness-like reaction to cefuroxime: a case report and review... - Jul 1, 2007 ...(8) A later study examined patients with SSLR to cefaclor, and found no in vitro cross-reactivity with loracarbef, another second-generation cephalosporin. ... $4.95 - Journal of Drugs in Dermatology - ECNext Urinary Tract Infection Medications - Urinary Tract Infection Health ... - Oct 2, 2008 Cephalosporins used for treatment of UTIs include cephalexin (Keflex), cefadroxil (Duricef) cefuroxime (Ceftin),loracarbef (Lorabid), and cefixime (Suprax, ... New York Times Sinusitis Medications - Sinusitis Health Information - NY Times Health - Jan 23, 2008 Second generation include cefaclor (Ceclor), cefuroxime (Ceftin), cefprozil (Cefzil), and loracarbef (Lorabid). Third generation include cefpodoxime ... New York Times Cystitis - Acute Bacterial Medications - Cystitis - Acute Bacterial... - Sep 18, 2008 Cephalosporins used for treatment of UTIs include cephalexin (Keflex), cefadroxil (Duricef) cefuroxime (Ceftin),loracarbef (Lorabid), and cefixime (Suprax, ... New York Times Article: Jamison Helps Push Wizards Above .500 - The Washington Post... - Dec 23, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Washington Post - HighBeam Research Article: Jamison, Wizards Continue Hot Streak; Forward's 33 Points... - Dec 22, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Washington Post - HighBeam Research Article: Wolves gameday; 7 PM VS. SACRAMENTO - T. CENTER - FSN, … - Jan 31, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Star Tribune - HighBeam Research Article: Kings let one slip away to Peoria. - Sun (Yuma, AZ) |... - Aug 30, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - The Sun - HighBeam Research Article: Stars-Kings preview: 3 pm today, American Airlines Center, … - Jan 15, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Dallas Morning News - HighBeam Research Article: Phoenix outlasts Nets in instant classic - Deseret News... - Dec 8, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Deseret News - HighBeam Research Evaluation of Poststreptococcal Illness - May 15, 2005 This was true even when the analysis was limited to the highest quality studies, although it did not apply to cefaclor (Ceclor) and loracarbef (Lorabid). ... AAFP News Now King Pharmaceuticals Completes Review Of Returns Reserve. - Feb 22, 2005 ...(ii) an impairment of intangible assets and write-off of excess purchase commitments associated with Lorabid(R) (loracarbef), and, as previously ... $4.95 - PR Newswire - ECNext Article: Bask: Rychart delivers 40 points as Sixers down Kings - AAP ... - Jan 15, 2005 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - AAP Sports News - HighBeam Research Article: Sonics get Lewis back, fall to Kings - Oakland Tribune |... - Feb 11, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Oakland Tribune - HighBeam Research Article: 'Kings,' 'Nightmare' top IndieWire poll.(Kings and Queen... - Dec 30, 2005 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily Variety - HighBeam Research Article: Bask: Redhage shakes of concussion to give Kings a headache ... - Feb 27, 2008 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - AAP Sports News - HighBeam Research Article: CALL THIS ONE A LOSS FOR KINGS DALLAS RALLIES FROM 4- … - Oct 6, 2005 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: KINGS FALTER LATE IN DEFEAT NHL: THIRD-PERIOD GOAL BY … - Jan 4, 2008 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: SLOW START HURTS KINGS IN END LA'S LATE SURGE IS NOT … - Dec 9, 2005 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: Three Kings.(Brief article)(Children's review)(Book review) ... - Feb 1, 2008 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Children's Bookwatch - HighBeam Research Article: Bask: Kings thump Breakers in NZ - AAP Sports News (Australia... - Dec 6, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - AAP Sports News - HighBeam Research Article: Stories About Naboth the Jezreelite: A Source, Composition,... - Feb 1, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Reference & Research Book News - HighBeam Research Article: Jazz Win 7th Straight 110-101 Over Kings - AP Online |... - Nov 23, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Artest Scores 36; Kings Never Look Back - AP Online |... - Jan 25, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Press Release: From the Creators Of The Smash Hit Celtic Woman … - Jan 8, 2008 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - PR Newswire - HighBeam Research Montana Administrative Rules - 24.111.511 NATUROPATHIC … - Aug 9, 2005 ...(viii) ceftriaxone; (ix) cephradine; and (x) loracarbef; (c) erythromycin and its salts: (i) azithromycin; (ii) clarithromycin; and (iii) nitromide; ... Pay-Per-View - Montana Administrative Rules - Loislaw Article: Nuggets Spoil Artest's Return to Kings - AP Online |... - Mar 11, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Press Release: King Pharmaceuticals Completes Review Of Returns … - Feb 22, 2005 ...(ii) an impairment of intangible assets and write-off of excess purchase commitments associated with Lorabid(R) (loracarbef), and, as previously ... Pay-Per-View - PR Newswire - HighBeam Research Article: LATE SURGE CRUCIAL IN KINGS VICTORY THREE GOALS IN … - Mar 19, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: Martin Carries Kings to 3rd Straight Win - AP Online |... - Mar 4, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Jazz Win 7th Straight 110-101 Over Kings - AP Online |... - Nov 23, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: A NIGHT TO REMEMBER FOR KINGS DESPITE SHORT- … - Jan 3, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: Kings Trade Norstrom to Dallas - AP Online | HighBeam... - Feb 27, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Kings Down Hawks to Snap 5-Game Skid - AP Online | HighBeam ... - Dec 11, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Artest Scores 36; Kings Never Look Back - AP Online |... - Jan 25, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Wade Leads Heat to 93-91 Win Over Kings - AP Online | … - Dec 8, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Dalembert Helps 76ers Roll Past Kings - AP Online | HighBeam... - Feb 27, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: BRIEFLY.(Sports) - Daily News (Los Angeles, CA) | HighBeam … - Jan 14, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Rethinking partnership.(NEXT-STAGE LICENSING: JOSEPH BRINDISI)( … - Mar 1, 2007 ...a prescription allergy eye drop promoted by Alcon: Lorabid (loracarbef), an oral antibiotic, which was licensed to Eli Lilly and is now marketed by King ... $4.95 - Pharmaceutical Executive - ECNext Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ... - Aug 4, 2005 ...(529.5) Lopinavir; (529.7) Loracarbef; (529.9) Loratadine — See exceptions; (529.95) Losartan; (529.97) Loteprednol; (530) Lovastatin; (530.5) Loxapine; ... Pay-Per-View - Georgia Code - Loislaw Article: Kings Down Hawks to Snap 5-Game Skid - AP Online | HighBeam ... - Dec 11, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Bask: Worthington is x-factor for Kings - AAP Sports News ( … - Feb 3, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - AAP Sports News - HighBeam Research Article: YOUNG KINGS AIM TO BE CROWNED TEAM WILL OPEN … - Sep 28, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: KINGS AREN'T FEELING HOMELY PHOENIX 6, KINGS 2.(Sports) … - Mar 15, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: LATE SURGE CRUCIAL IN KINGS VICTORY THREE GOALS IN … - Mar 19, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Daily News - HighBeam Research Article: Wade Leads Heat to 93-91 Win Over Kings - AP Online | … - Dec 8, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Martin's 35 Helps Kings Trip Sonics - AP Online | HighBeam … - Nov 25, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Hagman Helps Stars Beat Kings Again, 5-1 - AP Online | … - Oct 11, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Nowitzki, Howard Help Mavs Crown Kings - AP Online | … - Dec 19, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Webber Triumphant in Return to Sacramento - AP Online | … - Jan 4, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - AP Online - HighBeam Research Article: Kings fall prey to Predators. - Orange County Register... - Dec 7, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Orange County Register - HighBeam Research Article: Kings Down Hawks to Snap 5-Game Skid - AP Online | HighBeam ... - Dec 11, 2006 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: COMMENTARY: Desert Storm: Coachella - University Wire | … - May 4, 2007 Eli Lilly and Company (NYSE: LLY) announced ... that they have signed a definitive agreement for King to acquire the antibiotic Lorabid(R) (loracarbef . ... Pay-Per-View - University Wire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |